NUDT15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.88178419700125E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.00900407421045E-11 |
Normal-vs-Stage2 |
1.79899999996902E-06 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
3.85724785445518E-12 |
Stage1-vs-Stage2 |
8.405600E-01 |
Stage1-vs-Stage3 |
3.6770999999991E-05 |
Stage1-vs-Stage4 |
8.644300E-03 |
Stage2-vs-Stage3 |
1.317720E-02 |
Stage2-vs-Stage4 |
1.132770E-01 |
Stage3-vs-Stage4 |
3.968000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62547753035369E-12 |
Normal-vs-AfricanAmerican |
3.11840000044583E-07 |
Normal-vs-Asian |
8.808800E-04 |
Caucasian-vs-AfricanAmerican |
2.669600E-01 |
Caucasian-vs-Asian |
6.226400E-01 |
AfricanAmerican-vs-Asian |
3.469400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.44009282066327E-15 |
Normal-vs-Female |
2.88780110935249E-12 |
Male-vs-Female |
7.033000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.86165999999099E-05 |
Normal-vs-Age(41-60Yrs) |
1.68709490822039E-12 |
Normal-vs-Age(61-80Yrs) |
1.67144076357317E-12 |
Normal-vs-Age(81-100Yrs) |
5.78509999999977E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.527600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.073600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.497400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.983600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.113800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.522000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.714100E-02 |
Normal-vs-Grade 2 |
2.15759999866449E-08 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
4.689400E-01 |
Grade 1-vs-Grade 3 |
1.991630E-02 |
Grade 1-vs-Grade 4 |
2.958600E-04 |
Grade 2-vs-Grade 3 |
7.59000000000176E-05 |
Grade 2-vs-Grade 4 |
8.73219996311292E-09 |
Grade 3-vs-Grade 4 |
6.722500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.20540000098291E-08 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
1.88969999981303E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63813407283442E-12 |
Normal-vs-N1 |
2.38439999966644E-07 |
N0-vs-N1 |
1.952230E-01 |
|
|